EMG
RDY icon

Ellington Management Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Ellington Management Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,000
Closed -$202K – 625
2014
Q1 		$202K Buy
+23,000
New +$200K 0.06% 525

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
HGI
Hansberger Global Investors Ft Lauderdale, Florida $354M AUM 17.2% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Ellington Management Group's RDY Position: Q2 2014 in Review

Ellington Management Group sold out of Dr. Reddy's Laboratories (RDY) in Q2 2014, closing a stake of 23,000 shares — an estimated $202K sold.

Ellington Management Group first reported a position in RDY in Q1 2014 and held it in 1 quarter. The position peaked at $202K in Q1 2014. 169 funds tracked by Wall St. Rank hold RDY as of Q2 2014.

  • Ellington Management Group reported no remaining Dr. Reddy's Laboratories position as of Q2 2014 after selling out during the quarter.
  • Ellington Management Group sold 23,000 Dr. Reddy's Laboratories shares in Q2 2014, an estimated $202K.
  • Ellington Management Group first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 1 quarter.
  • Ellington Management Group's Dr. Reddy's Laboratories position peaked at $202K in Q1 2014.
  • 169 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2014.

Based on Ellington Management Group's 13F filing for Q2 2014, filed 14 Aug 2014.